DocSym
β
Searchsearch
Search
(Y43.1) Antineoplastic antimetabolites
More details coming soon
74 096 in individuals diagnosis antineoplastic antimetabolites confirmed
2 382 deaths with diagnosis antineoplastic antimetabolites
3% mortality rate associated with the disease antineoplastic antimetabolites
Diagnosis antineoplastic antimetabolites is diagnosed Women are 33.74% more likely than Men
24 547
Men receive the diagnosis antineoplastic antimetabolites
789 (3.2 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
49 549
Women receive the diagnosis antineoplastic antimetabolites
1 593 (3.2 %)Died from this diagnosis.
Risk Group for the Disease antineoplastic antimetabolites - Men aged 65-69 and Women aged 60-64
In Men diagnosis is most often set at age 0-14, 20-29, 35-39, 45-74, 80-84
Less common in men the disease occurs at Age 0-1, 15-19, 30-34, 40-44, 75-79, 85-95+Less common in women the disease occurs at Age 0-5, 25-29, 35-39, 90-95+
In Women diagnosis is most often set at age 5-24, 30-34, 40-89
Disease Features antineoplastic antimetabolites
Absence or low individual and public risk
Antineoplastic antimetabolites - what does this mean
Antineoplastic antimetabolites are drugs that act as inhibitors of cell metabolism, interfering with the biochemical pathways necessary for the growth and division of cancer cells. these drugs work by disrupting the synthesis of dna, rna, and proteins, which are essential for the growth and survival of cancer cells.
What happens during the disease - antineoplastic antimetabolites
Antineoplastic antimetabolites are drugs that interfere with the metabolic processes of cancer cells, preventing them from growing and reproducing. they work by targeting specific molecules that are essential for the growth and reproduction of cancer cells, such as dna and rna, and by preventing these molecules from being produced or utilized. this in turn prevents the cancer cells from synthesizing proteins and other components necessary for their growth and reproduction, leading to their death.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical exam
- Blood tests
- Imaging tests (X-ray, CT scan, MRI)
- Biopsy
- Urine tests
- Genetic testing
Treatment and Medical Assistance
Main goal of the treatment: To reduce the growth of cancer cells
- Administering antineoplastic antimetabolites
- Monitoring the patient's vital signs
- Providing supportive care, such as pain relief
- Regularly assessing the patient's response to treatment
- Adjusting the dosage of antineoplastic antimetabolites as needed
- Monitoring for side effects of the medication
- Providing education and support to the patient and their family
12 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Antineoplastic antimetabolites - Prevention
Antineoplastic antimetabolites can be prevented by avoiding exposure to known carcinogens, eating a healthy diet rich in fruits and vegetables, exercising regularly, avoiding smoking, and getting regular health screenings.